Meaning and medication: a thematic analysis of depressed adolescents' views and experiences of SSRI antidepressants alongside psychological therapies
- PMID: 30486802
- PMCID: PMC6263068
- DOI: 10.1186/s12888-018-1961-y
Meaning and medication: a thematic analysis of depressed adolescents' views and experiences of SSRI antidepressants alongside psychological therapies
Abstract
Background: Adolescence is a key period of risk for the emergence of Major Depressive Disorder (MDD). The prescription of selective serotonin re-uptake inhibitors (SSRIs) for the treatment of depression in adolescents is an issue of worldwide controversy, and evidence regarding their safety and efficacy is inconclusive. In the UK, NICE guidelines have recently recommended offering SSRIs to adolescents alongside psychological therapy or on their own if therapy is refused. Thus, SSRIs are increasingly becoming a major component of treatment for adolescents. This study qualitatively explored adolescents' views and experiences of SSRIs within their accounts of engaging in a psychological therapy for depression, particularly focusing on meanings they attached to medication-use.
Methods: The qualitative study reports data from semi-structured interviews conducted 12-months post-treatment with 12 adolescents who were clinically referred and treated for depression as part of the IMPACT trial. The interviews were analysed using Thematic Analysis.
Results: Four themes were identified: 'a perceived threat to autonomy', 'a sign of severity', 'a support, not a solution', and 'an ongoing process of trial and error'.
Conclusions: This study highlights the value of bringing adolescents' voices into the broader debate on the use of antidepressants in their age group and in the development of future guidelines. Future implications for research and clinical practice are discussed.
Keywords: Adolescents; Antidepressants; Depression; Medication use; Patient perspectives; Qualitative; SSRIs.
Conflict of interest statement
Authors’ information
Not Applicable.
Ethics approval and consent to participate
IMPACT-ME received ethics approval from the Cambridgeshire-2 Research Ethics Committee, Addenbrookes Hospital, Cambridge, UK (REC Ref: 09/H0308/137). Written consent was obtained from all adolescents and parents. Pseudonyms were used to maintain anonymity and identifiable details are excluded or disguised.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Fonagy P, Cottrell D, Phillips J, Bevington D, Glaser D, Allison E. Chapter 3: Depressive disorders. In: Fonagy P, Cottrell D, Phillips J, Bevington D, Glaser D, Allison E, editors. What works for whom? A critical review of treatments for children and adolescents (2nd ed.) New York: The Guilford Press; 2015. pp. 74–119.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources